Basic Energy Services (NYSE:BAS), Amazon.com (NASDAQ:AMZN), Antares Pharma Inc. (NASDAQ:ATRS), China Cord Blood Corporation (NYSE:CO), Laboratory Corp. of America (NYSE:LH)


On Friday shares of Basic Energy Services, Inc. (NYSE:BAS) closed at $8.70. Company’s sales growth for last 5 years was 23.10% and EPS growth for next 5 years is recorded as 6.00%. On April 23, Basic Energy Services, Inc. (NYSE:BAS) announced its financial and operating results for the first quarter ended March 31, 2015. First quarter 2015 revenue declined 35% to $261.7 million from $400.9 million in the fourth quarter of 2014 as all lines of services experienced reduced activity levels and pricing pressures.

Amazon.com, Inc. (NASDAQ:AMZN) in last trading activity moved up 14.13% to close at $445.10. Company weekly performance is 18.52% while its quarterly performance stands at 42.48%. Amazon.com, Inc. (NASDAQ:AMZN) is 12.80% away from its 52 week high. On April 23, Amazon.com, Inc. (NASDAQ:AMZN) announced financial results for its first quarter ended March 31, 2015. Operating cash flow increased 47% to $7.84 billion for the trailing twelve months, compared with $5.35 billion for the trailing twelve months ended March 31, 2014. Free cash flow increased to $3.16 billion for the trailing twelve months, compared with $1.49 billion for the trailing twelve months ended March 31, 2014.

On last trading day Antares Pharma Inc. (NASDAQ:ATRS) moved down -1.45% to close at $2.72. Its volatility for the week is 3.43% while volatility for the month is 4.37%. ATRS’s sales growth for past 5 years was 26.10% and its EPS growth for past 5 years was -14.00%. Antares Pharma Inc. (NASDAQ:ATRS) monthly performance is 5.84%. Antares Pharma, Inc. (NASDAQ:ATRS) announced that it has regained U.S. marketing rights to OTREXUP (methotrexate) injection for subcutaneous use for the psoriasis indication through the termination of an exclusive promotion and marketing agreement with LEO Pharma A/S for detailing OTREXUP to dermatologists for symptomatic control of severe recalcitrant psoriasis in adults.

China Cord Blood Corporation (NYSE:CO) has 87.60% insider ownership while its institutional ownership stands at 29.70%. In last trading activity company’s stock closed at $7.22. China Cord Blood Corporation (NYSE:CO) announced that its board of directors has received a non-binding proposal letter from Golden Meditech Holdings Limited (“Golden Meditech”), pursuant to which Golden Meditech proposes to acquire all of the outstanding ordinary shares of the Company not already directly or indirectly owned by Golden Meditech for US$6.40 per ordinary share in cash.

On last trading day Laboratory Corp. of America Holdings (NYSE:LH) moved up 0.44% to close at $126.93. Its volatility for the week is 1.20% while volatility for the month is 1.38%. LH’s sales growth for past 5 years was 5.10% and its EPS growth for past 5 years was 3.50%. Laboratory Corp. of America Holdings (NYSE:LH) monthly performance is 0.03%. Laboratory Corporation of America® Holdings (NYSE:LH) announced results for the quarter ended March 31, 2015. Net revenue for the quarter was $1.77 billion, an increase of 23.9% over last year’s $1.43 billion. The acquisition of Covance contributed $267.2 million from the date of closing on February 19, 2015, driving 18.7% year over year net revenue growth.


Leave a Reply

Your email address will not be published. Required fields are marked *